Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesDigital X-RayAre x-rays of lacerations necessary?A study supports a shift toward more selective imaging criteria for x-rays of lacerations.MRIMRI helps predict adverse outcomes in heart failure patientsWomens ImagingCEM improves cancer detection when added to screening DBT examsCTDL algorithm shows promise for opportunistic CAC evaluation on CTSponsor ContentRegister today for our June 17 webinar
